140 related articles for article (PubMed ID: 25731374)
21. Combining Fulvestrant with Low-Dose Capecitabine is Effective and Tolerable in Woman with Metastatic Breast Cancer.
Nakai M; Takei H; Yanagihara K; Yamashita K; Uchida E
J Nippon Med Sch; 2016; 83(2):81-6. PubMed ID: 27180793
[TBL] [Abstract][Full Text] [Related]
22. [A Case of Stage IV Breast Cancer with Extensive Metastasis Successfully Treated with S-1 plus Anastrozole Therapy].
Mugitani T; Hatakeyama T; Sakai T; Matsumura A; Ogino S; Akami T; Okano S
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1479-1481. PubMed ID: 29394674
[TBL] [Abstract][Full Text] [Related]
23. [A case of solitary adrenal metastasis from breast cancer successfully resected by laparoscopy].
Mizuyama Y; Shinto O; Tamura T; Nakagawa H; Ohno Y; Takashima T; Ishikawa T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2351-3. PubMed ID: 24394109
[TBL] [Abstract][Full Text] [Related]
24. [A case of locally advanced and metastatic breast cancer successfully treated with combination therapy of paclitaxel and bevacizumab].
Miki M; Matsuo Y; Yoshida S; Tane K; Hirokaga K; Maekawa Y; Takao S
Gan To Kagaku Ryoho; 2014 Aug; 41(8):1027-9. PubMed ID: 25132039
[TBL] [Abstract][Full Text] [Related]
25. Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
Koolen BB; Valdés Olmos RA; Wesseling J; Vogel WV; Vincent AD; Gilhuijs KG; Rodenhuis S; Rutgers EJ; Vrancken Peeters MJ
Ann Surg Oncol; 2013 Jul; 20(7):2227-35. PubMed ID: 23456316
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
27. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
[TBL] [Abstract][Full Text] [Related]
28. [A case of recurrent breast cancer that responded to bevacizumab].
Hagino S; Iwata K; Nakura M; Yoshizumi T; Tsuneda A; Kiriyama M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2390-2. PubMed ID: 24394122
[TBL] [Abstract][Full Text] [Related]
29. [A case of recurrent breast cancer with carcinomatous pleurisy responding to bevacizumab and paclitaxel therapy].
Sato Y; Nakagawa T; Sato T; Nagahara M; Sugihara K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2387-9. PubMed ID: 24394121
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
31. Quantitative ER and PgR assessment as predictors of benefit from lapatinib in postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.
Finn RS; Press MF; Dering J; O'Rourke L; Florance A; Ellis C; Martin AM; Johnston S
Clin Cancer Res; 2014 Feb; 20(3):736-43. PubMed ID: 24198242
[TBL] [Abstract][Full Text] [Related]
32. [A Case of Pure Squamous Cell Carcinoma of the Breast in an Elderly Woman Diagnosed by Cytology].
Sato Y; Inatome J; Okishiro M; Oneda Y; Ishida T; Morimoto Y; Kuwahara R; Kusama H; Naito A; Murakami K; Katsura Y; Ohmura Y; Kagawa Y; Takeno A; Egawa C; Takeda Y; Kato T; Tamura S; Takatsuka Y; Goto T; Nagano T; Nakatsuka S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2259-2261. PubMed ID: 28133288
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
34. Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology Research Consortium.
Yardley DA; Burris HA; Clark BL; Shipley D; Rubin M; Barton J; Arrowsmith E; Hainsworth JD
Clin Breast Cancer; 2011 Jun; 11(3):146-52. PubMed ID: 21665134
[TBL] [Abstract][Full Text] [Related]
35. [A case of bone marrow carcinomatosis with disseminated intravascular coagulation arising from breast cancer successfully treated with paclitaxel plus bevacizumab].
Kawai H; Sugimoto R; Miyauchi S; Yoshida R; Waki N; Hirayama S; Ishizaki M; Nishi H; Yamashita K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1957-9. PubMed ID: 25731388
[TBL] [Abstract][Full Text] [Related]
36. Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609).
Lerebours F; Rivera S; Mouret-Reynier MA; Alran S; Venat-Bouvet L; Kerbrat P; Salmon R; Becette V; Bourgier C; Cherel P; Boussion V; Balleyguier C; Thibault F; Lavau-Denes S; Nabholz JM; Sigal B; Trassard M; Mathieu MC; Martin AL; Lemonnier J; Mouret-Fourme E
Cancer; 2016 Oct; 122(19):3032-40. PubMed ID: 27315583
[TBL] [Abstract][Full Text] [Related]
37. [A case of recurrent breast cancer with extensive liver metastasis successfully treated with endocrine therapy].
Kiyoto S; Hara F; Osumi S; Takabatake D; Takashima S; Aogi K; Takashima S
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2623-5. PubMed ID: 20009467
[TBL] [Abstract][Full Text] [Related]
38. A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancer.
Jerusalem G; Bachelot T; Barrios C; Neven P; Di Leo A; Janni W; de Boer R
Cancer Treat Rev; 2015 Feb; 41(2):94-104. PubMed ID: 25575443
[TBL] [Abstract][Full Text] [Related]
39. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.
Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N
Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757
[TBL] [Abstract][Full Text] [Related]
40. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]